MÖMurat Oğuz Özilhan

Murat Oğuz Özilhan

*This is an algorithmically generated author record based on publicly available information.

Murat Oğuz Özilhan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The predictive role of systemic immune-inflammation index in non-ischemic cardiomyopathy

    by Murat Oğuz Özilhan, Gökhan Gökalp

    Aims: The systemic immune-inflammation index (SII), a useful marker of systemic inflammation, has been shown to be associated with cardiovascular diseases in previous studies. Inflammation is known to have a significant role in heart failure, but no study has evaluated the relationship between inflammatory parameters and prognosis in patients with non-ischemic cardiomyopathy (NICM). This study aimed to explore the relationship between SII and long-term mortality in patients with non-ischemic cardiomyopathy. Methods: The study enrolled 326 consecutive patients with NICM. The median 25-month follow-up mortality results of the patients were recorded retrospectively. SII, a combined index based on the count of three parameters, was calculated as follows: neutrophil count x platelet count/lymphocyte count. Patients with a higher SII value than the median SII were accepted as having a high SII, and the remaining patients were defined as having a low SII. The survival curves of the patients with high and low SII values during the study period were analyzed using the Kaplan-Meier method. Results: The mean age of the participants was 46.6 years. The mean SII value was 598.4 in patients without mortality and 722.7 in those with mortality. In the multivariate logistic regression analysis, SII was found to be an independent predictor of mortality. The median SII value of the patients who participated in the study was 644. Upon dividing the patients into two groups according to the median SII value, the mortality rate was determined to be 48.4% in the high SII group and 27.4% in the low SII group. Conclusion: High SII values were observed to be associated with long-term mortality in patients with NICM. SII, which is easily accessed and simply calculated, can be used to predict mortality risk in these patients. Prospective and larger cohort studies are needed to clarify the causality of this relationship.


  • Open Access

    Evaluation of the relationship between mitral annular calcification and triglyceride-glucose index

    by Gökhan Gökalp, Nail Burak Özbeyaz, Murat Oguz Özi̇lHan

    Aims: Mitral annular calcification (MAC) is an echocardiographic condition with a multicomponent etiopathogenesis, one of which is insulin resistance. Triglyceride-glucose (TyG) index is an excellent biochemical parameter that has proven itself in determining insulin resistance in recent years. This study aims to reveal the relationship between the TyG index and the presence of MAC. Methods: The study included 159 patients with MAC and 167 control group. The control group has similar demographic characteristics such as age, gender, presence of hypertension (HT), and diabetes mellitus with the MAC group. TyG index was calculated as a formula: ln[fasting triglyceride (mg/dl) × fasting plasma glucose (mg/dl)/2]. Results: The mean age of the patients was 74.2 and 48.2% of the patients were male. Coronary artery disease (CAD) (p: 0.031), glucose (p:0.001), total cholesterol (p:0.009), low-density lipoprotein (LDL) (p:0.004), triglyceride (TG) (p


  • Predictors of Complete Atrioventricular Block Following Transcatheter Aortic Valve Replacement

    by Murat Oğuz Özilhan, Sadık Kadri Açıkgöz, Özge Çakmak Karaaslan, Erdeniz Eriş, Gökhan Gökalp, Hatice Selçuk, Mehmet Timur Selçuk, Orhan Maden


  • Open Access

    The Prognostic Nutritional Index in prediction of two-year mortality in patients undergoing Transcatheter Aortic Valve Replacement

    by Murat Oguz Ozilhan, Sadık Kadri Açıkgöz

    Objective: Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure employed to treat aortic valve disease in patients who are ineligible for open-heart surgery. Undergoing TAVR patients generally include the elderly and frail. Malnutrition is associated with high morbidity and mortality in patients with undergoing TAVR. The aim of this study was to investigate the prognostic value of the prognostic nutritional index (PNI) for two-year survival after TAVR. Material and Methods: A cohort of 213 consecutive patients with severe aortic stenosis who underwent transcatheter aortic valve replacement between March 2019 and July 2021. The study population was divided into two groups according to the cut-off PNI level in a receiver operator characteristic (ROC) curve analysis. The two-year follow-up results of the patients were recorded retrospectively. PNI was defined according to the following formula: PNI = (10 x serum albumin [g/dl]) + (0.005 x total lymphocyte counts [1000/mcL]). Results: Mean age of the patients was 76.15, and 93 (43.7%) of them were males. Patients with low PNI (group 1) were significantly older. The mean PNI of group 1 was 43.17 ± 4.04 and the mean PNI of group 2 was 54.23 ± 4.30. Mortality at two-year was 32.6% in low PNI group and 10.7% in high PNI group. Hypertension and PNI were independent predictors of mortality after TAVR. In ROC curve analysis, PNI at a cut off value of 48.325 predicted the mortality after TAVR with 63.5% sensitivity and 70.1% specificity. Kaplan-Meier curves for two-year mortality between low and high PNI groups showed worse outcomes in patients with low PNI. Conclusion: PNI is a practical and useful nutritional index that predicts two-year mortality after TAVR.


  • Open Access

    THE PREDICTORS OF MORTALITY IN PATIENTS WHO WERE REFERRED TO CORONARY ANGIOGRAPHY DUE TO MYOCARDIAL INFARCTION AND HAD COVID-19

    by Cem Çöteli̇, Furkan Külekçi̇, Özge Çakmak Karaaslan, Murat Oğuz Özi̇lHan, Emre Aruğaslan, Havva Tuğba Gürsoy, Mehmet Aki̇f Erdöl, Serdal Baştuğ, Ahmet Kasapkara

    Giriş: Miyokard enfarktüsü tablosu ile başvuran COVID-19 hastalarında mortalite ve morbidite verileri hastaların uzun süreli takiplerinin olmaması nedeniyle kısıtlıdır. Bu çalışmada bu hasta grubunun mortalite prediktörlerinin araştırılması amaçlanmıştır. Yöntemler: COVID-19 enfeksiyonu mevcut olan ve yüksek riskli miyokard enfarktüsü nedeniyle invaziv koroner anjiyografi yapılan 80 hasta çalışmaya dahil edilmiştir. Tüm hastalar ilk başvurudan sonra en az 1 yıl süre ile takip edilmiştir. Hastaların mortalite verileri ve medikal kayıtları hastanenin medikal kayıt programından retrospektif olarak alınmıştır. Bulgular: Otuz dört hastanın (%42,5) ilk başvurudan sonraki bir yıllık takipte öldüğü izlendi. Bu hastaların 30’u (%88,2) ilk başvurudaki hastane yatışı sonlanmadan öldü. Medyan kapı balon süresi 107,5 dk (17-1278) olarak izlendi. 49 hastaya (%61,25) invaziv koroner anjiyografi sırasında perkütan koroner girişim uygulandı. Yüksek ferritin ve LDH seviyelerinin mortalite ile bağımsız olarak ilişkili olduğu izlendi (OR: 1,006, CI %95: 1,001-1,01, p: 0,011; OR:1,005, CI %95: 1,001-1,009, p:0,025; sırasıyla). Ferritin için kestirim değeri 211 mcg/L (AUC:0.762, sensitivite: 73.5%, spesifite 63%, p:<0.001) ve LDH için kestirim değeri 492 U/L (AUC:0.863, sensitivite: 79.4%, spesifite 80.4%, p:<0.001) olarak hesaplandı. Sonuç: İnvaziv medikal tedaviye rağmen miyokard enfarktüsü gelişen COVID-19 hastalarında mortalite oranı yüksektir. Çalışmada artmış LDH ve ferritin seviyelerinin mortalite prediktörü olduğu izlenmiştir.


  • Serum total bilirubin level is associated with contrast induced nephropathy after primary percutaneous coronary intervention

    by Murat Oğuz Özilhan, Sadık Kadri Açıkgöz

    Contrast Induced Nephropathy (CIN) is a major complication of angiographic procedures. Primary percutaneous coronary intervention (pPCI) is the preferred treatment for ST-segment elevation myocardial infarction (STEMI) but is associated with a risk of CIN. Oxidative stress and free radical damage play a role in the pathogenesis of CIN. Bilirubin has anti-inflammatory and antioxidant activity and has been shown to have a protective effect on endothelial cells. The present study aimed to assess the association between serum bilirubin level and development of CIN after pPCI. Sequential STEMI patients (n = 595) who underwent pPCI between January 2021 and December 2022 were enrolled. Among the participants, 116 (19.5%) developed CIN. Serum total bilirubin level was significantly lower in the CIN group ( P = .001). In multivariate logistic regression analysis, serum bilirubin level was found as an independent predictor of CIN. Age, gender, contrast volume, and white blood cell count were other independent predictors of CIN. A higher serum bilirubin level is associated with a lower risk of CIN in the present study. In STEMI patients undergoing pPCI, serum bilirubin level may be helpful to predict the risk of CIN and may help ensure early initiation of preventive treatment and careful follow-up.


  • Systemic inflammation response index is associated MACE in patients with NSTEMI

    by M. O. Ozilhan, O. Cakmak Karaaslan, S. K. Acikgoz, H. Selcuk, M. T. Selcuk, O. Maden

    OBJECTIVE: Non-ST segment elevation myocardial infarction (NSTEMI) poses a significant health concern. The systemic inflammation response index (SIRI), an emerging inflammatory marker linked to conditions like stroke and cancer, has shown potential relevance. Inflammation's pivotal role in acute coronary syndromes is well-established, yet its specific association with NSTEMI and SIRI remains unexplored. This study aims to elucidate the correlation between SIRI and major adverse cardiovascular events ( MACE) in patients with NSTEMI. PATIENTS AND METHODS: A cohort of 935 consecutive NSTEMI patients who underwent percutaneous intervention was recruited. MACE was defined to encompass all-cause death, malignant arrhythmia, and unplanned percutaneous coronary intervention. The systemic inflammation response index, a composite metric involving three distinct inflammatory cell counts, was computed as the product of neutrophil count and monocyte count divided by lymphocyte count. A receiver operator characteristic (ROC) curve analysis was used to define a cut-off level of SIRI to predict MACE. Then, the study population was divided into two groups according to the cut-off SIRI level in ROC curve analysis. The 12-month follow-up results of the patients were recorded retrospectively. RESULTS: The participants exhibited a mean age of 64.12. Notably, the mean SIRI level registered at 1.98 among patients experiencing MACE and 4.97 among others. Through rigorous multivariate logistic regression analysis, SIRI emerged as an independent predictor of MACE. Further analysis via ROC curve yielded a sensitivity of 68% and specificity of 76% for MACE detection, with a SIRI cut-off of 2.3. CONCLUSIONS: In the context of NSTEMI, SIRI emerges as a robust independent predictor of MACE. These findings underscore the potential utility of SIRI as a prognostic indicator for adverse cardiovascular events, enhancing our understanding of the disease's pathophysiological mechanisms and potential avenues for improved clinical management.


  • Cystatin C and Its Temporal Change May Predict Development and Recovery of Cardio-renal Syndrome Type 1 in Acute Heart Failure

    by Eser Açıkgöz, Sadık Kadri Açıkgöz, Murat Oğuz Özilhan, Mustafa Candemir, Gökhan Gökalp, Özge Çakmak Karaaslan, Serdar Gökhan Nurkoç, Ajar Koçak, Gülbahar Özlem, Hüseyin Murat Özdemir